Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT ...

Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim ...

JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha ...

(RTTNews) - Alpha Tau Medical Ltd. (DRTS), an Israeli oncology therapeutics company, on Monday announced promising interim data from multiple clinical trials involving its Alpha DaRT therapy.

You've probably noticed a symbol on an ambulance featuring a snake inside a six-point star, but you may not realize how it ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Alpha Tau (DRTS) Medical announced an approval from the U.S. Food and Drug Administration, FDA, of an Investigational Device Exemption IDE, supplement to the IDE previously announced on Jan 27 ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of research from the University of Gothenburg, which also offers ...

JERUSALEM, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha ...